Immuneering (IMRX) - 2022 Q4 - Earnings Call Transcript
Immuneering (IMRX)2023-03-07 11:50
Immuneering Corporation (NASDAQ:IMRX) Q4 2022 Earnings Conference Call March 6, 2023 4:30 PM ET Company Participants Laurence Watts - Investor Relations, Gilmartin Group Benjamin Zeskind - President and Chief Executive Officer Brett Hall - Chief Scientific Officer Scott Barrett - Chief Medical Officer Mallory Morales - Vice President of Finance, Treasurer Conference Call Participants Swapnil Malekar - Piper Sandler Jeffrey Hung - Morgan Stanley Mark Breidenbach - Oppenheimer & Co. Inc. Michael Schmidt - Gug ...